Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.
Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.
复制标题
DOI:
10.1182/blood.2022015646
复制
发表时间:
2022-11-03
期刊:
影响因子:
20.3
通讯作者:
Nakagawa, Masao
中科院分区:
文献类型:
--
作者:
Chiba, Masahiro;Shimono, Joji;Ishio, Takashi;Takei, Norio;Kasahara, Kohei;Ogasawara, Reiki;Ara, Takahide;Goto, Hideki;Izumiyama, Koh;Otsuguro, Satoko;Perera, Liyanage P.;Hasegawa, Hiroo;Maeda, Michiyuki;Hashino, Satoshi;Maenaka, Katsumi;Teshima, Takanori;Waldmann, Thomas A.;Yang, Yibin;Nakagawa, Masao
Adult T-cell leukemia/lymphoma (ATLL) is one of the aggressive peripheral T-cell neoplasms with a poor prognosis. Accumulating evidence demonstrates that escape from adaptive immunity is a hallmark of ATLL pathogenesis. However, the mechanisms by which ATLL cells evade natural killer (NK)-cell–mediated immunity have been poorly understood. Here we show that CD48 expression in ATLL cells determines the sensitivity for NK-cell–mediated cytotoxicity against ATLL cells. We performed unbiased genome-wide clustered regularly interspaced short palindromic repeat (CRISPR) screening using 2 ATLL-derived cell lines and discovered CD48 as one of the best-enriched genes whose knockout conferred resistance to YT1–NK cell line-mediated cytotoxicity. The ability of CD48-knockout ATLL cells to evade NK-cell effector function was confirmed using human primary NK cells with reduced interferon-γ (IFNγ) induction and degranulation. We found that primary ATLL cells had reduced CD48 expression along with disease progression. Furthermore, other subgroups among aggressive peripheral T-cell lymphomas (PTCLs) also expressed lower concentrations of CD48 than normal T cells, suggesting that CD48 is a key molecule in malignant T-cell evasion of NK-cell surveillance. Thus, this study demonstrates that CD48 expression is likely critical for malignant T-cell lymphoma cell regulation of NK-cell–mediated immunity and provides a rationale for future evaluation of CD48 as a molecular biomarker in NK-cell–associated immunotherapies. Whole-genome CRISPR library screening identified CD48 as a key molecule to define susceptibility to NK-cell–mediated cytotoxicity in ATLL. ATLL and other PTCLs had reduced CD48 expression compared with normal T cells, implicating a role of reduced CD48 in PTCL pathogenesis.
登录
查看更多内容
影响因子:
20.3
作者:
Elias S;Yamin R;Golomb L;Tsukerman P;Stanietsky-Kaynan N;Ben-Yehuda D;Mandelboim O
通讯作者:
Mandelboim O
影响因子:
20.3
作者:
de Leval, Laurence;Rickman, David S.;Gaulard, Philippe
通讯作者:
Gaulard, Philippe
影响因子:
20.3
作者:
Chen, Jing;Petrus, Mike;Waldmann, Thomas A.
通讯作者:
Waldmann, Thomas A.
影响因子:
82.9
作者:
Chapuy B;Stewart C;Dunford AJ;Kim J;Kamburov A;Redd RA;Lawrence MS;Roemer MGM;Li AJ;Ziepert M;Staiger AM;Wala JA;Ducar MD;Leshchiner I;Rheinbay E;Taylor-Weiner A;Coughlin CA;Hess JM;Pedamallu CS;Livitz D;Rosebrock D;Rosenberg M;Tracy AA;Horn H;van Hummelen P;Feldman AL;Link BK;Novak AJ;Cerhan JR;Habermann TM;Siebert R;Rosenwald A;Thorner AR;Meyerson ML;Golub TR;Beroukhim R;Wulf GG;Ott G;Rodig SJ;Monti S;Neuberg DS;Loeffler M;Pfreundschuh M;Trümper L;Getz G;Shipp MA
通讯作者:
Shipp MA
影响因子:
20.3
作者:
Bryceson, YT;March, ME;Long, EO
通讯作者:
Long, EO